cns neuroscience & therapeutics
Reported by creative-biolabs22 (at outlook) | March 7th, 2024 @ 08:32 AM
CNS drug discovery has been hampered by inadequate understanding or consideration of a number of factors. These include the complexity of brain anatomy and function; the neuro-PK with regard to the blood-brain barrier (BBB) transport and intra-brain distribution as well as the measures to study these processes; adequate biomarkers of CNS drug effects (neuro-PD), and the complex nature of CNS diseases. Also, the reductionist view and thereby lack of understanding of the interaction and interdependencies of all these factors have contributed to the high attrition rates of CNS drugs. Learn more: cns neuroscience & therapeutics
No comments found
Please Sign in or create a free account to add a new ticket.
With your very own profile, you can contribute to projects, track your activity, watch tickets, receive and update tickets through your email and much more.
Create new ticket
Create your profile
Help contribute to this project by taking a few moments to create your personal profile. Create your profile »
Creative Biolabs is proud to offer the innovative DNA immunization service to customize polyclonal and monoclonal antibodies. As an advanced strategy, DNA immunization enables the immunized hosts to in vivo produce interested antigens with common post-transcriptional modifications and then induce a powerful immune response.
creative-biolabs22 (at outlook)